Pharmaceutical - Canada

Filter

Current filters:

Canada

Popular Filters

1 to 25 of 36 results

Auxilium Pharma rejects Endo acquisition in favor of QLT deal

Auxilium Pharma rejects Endo acquisition in favor of QLT deal

22-09-2014

Auxilium Pharmaceuticals’ board of directors, after review of the unsolicited $2.2 billion takeover…

AuxiliumCanadaEndo InternationalMen's HealthMergers & AcquisitionsPharmaceuticalQLTUSA

Disparity between investment reports as Canada’s Rx&D warns of “serious challenges”

Disparity between investment reports as Canada’s Rx&D warns of “serious challenges”

18-09-2014

Canada’s trade group Research-Based Pharmaceutical Companies (Rx&D) has acknowledged that the environment…

CanadaFinancialPharmaceuticalResearchRx&D

Allergan says Pershing’s additional requests for meeting is not “meaningful development”

Allergan says Pershing’s additional requests for meeting is not “meaningful development”

15-09-2014

Hostile takeover target Allergan has said that value is what “really matters” in response to Pershing…

AllerganCanadaFinancialLegalPharmaceuticalUSAValeant Pharmaceuticals International

Canadian government commits funding to innovative brain research projects

Canadian government commits funding to innovative brain research projects

15-09-2014

Innovative research projects have been given new funding under the Canada Brain Research Fund, announced…

Brain Canada FoundationCanadaCanada Brain Research FundPharmaceuticalResearch

Nicox and Bausch + Lomb to co-promote latanoprostene bunod for glaucoma

Nicox and Bausch + Lomb to co-promote latanoprostene bunod for glaucoma

08-08-2014

International opthalmic company Nicox is to co-promote latanoprostene bunod with Bausch + Lomb, the eyecare…

Bausch & LombCanadaGlaucomaLatanoprost OphthalmicMarkets & MarketingNicOxOphthalmicsOpticsPharmaceuticalUSA

Patient involvement pilot for orphan drugs launches in Canada

Patient involvement pilot for orphan drugs launches in Canada

07-08-2014

Canada’s Minister of Health, Rona Ambrose, says that the government has launched a pilot project targeting…

CanadaHealth CanadaPharmaceuticalRare diseasesRegulationResearchRocheTreatment of chronic lymphocytic leukemia

Allergan attacks Valeant’s financial results

Allergan attacks Valeant’s financial results

06-08-2014

US Botox maker Allergan, the subject of a hostile $53 billion takeover attempt by Canada’s Valeant…

AllerganBusiness FinanceCanadaFinancialMergers & AcquisitionsPharmaceuticalUSAValeant PharmaceuticalsValeant Pharmaceuticals International

Valeant's revenue jumps 86% to hit $2 billion

Valeant's revenue jumps 86% to hit $2 billion

31-07-2014

Canadian pharma company Valeant, which is currently attempting a takeover of Allergan, reported a 12-fold…

AllerganBausch & LombCanadaFinancialPharmaceuticalValeantValeant Pharmaceuticals

Canada’s Health Minister moves on safe prescribing practices for drugs prone to abuse

Canada’s Health Minister moves on safe prescribing practices for drugs prone to abuse

29-07-2014

Canada’s Minister of Health, Rona Ambrose, has issued a national Call for Proposals to improve the…

CanadaNeurologicalPharmaceuticalRegulation

Novartis’ Bexsero has high uptake in first widespread public vaccination program against meningitis B

Novartis’ Bexsero has high uptake in first widespread public vaccination program against meningitis B

29-07-2014

Swiss drug major Novartis has announced initial results from a large-scale vaccination campaign using…

Anti-viralsBexseroCanadaMeningitis BNovartisPharmaceuticalResearch

Valeant takes Allergan's 'false and misleading statements' to Quebec and US financial regulators

Valeant takes Allergan's 'false and misleading statements' to Quebec and US financial regulators

22-07-2014

In the latest in an ongoing takeover attempt of Allergan by Valeant, Valeant has contacted financial…

AllerganBausch & LombCanadaFinancialPharmaceuticalRegulationUSAValeant Pharmaceuticals

New cancer drugs approvals in Canada delayed due to extra layer of bureaucratic review

New cancer drugs approvals in Canada delayed due to extra layer of bureaucratic review

21-07-2014

The organization that reviews oncology medicines in Canada may unnecessarily delay approvals while cancer…

BevacizumabCanadaFraser InstituteOncologyPharmaceuticalRegulation

Milestone appoints Francis Plat as chief medical officer

Milestone appoints Francis Plat as chief medical officer

21-07-2014

Quebec-based cardiovascular drug development specialist Milestone Pharmaceuticals has announced the appointment…

BoardroomCanadaCardio-vascularFrancis PlatMilestone PharmaceuticalsPharmaceutical

Canadian approval for Sunovion’s Aptiom

Canadian approval for Sunovion’s Aptiom

14-07-2014

USA-based drugmaker Sunovion Pharmaceuticals, a subsidiary of Japan’s Dainippon Sumitomo, has received…

AptiomBIA-2093-301CanadaDainippon Sumitomo PharmaEpilepsyNeurologicalPharmaceuticalRegulationSunovion Pharmaceuticals

UCB and Dermira link up for Cimzia in dermatology

UCB and Dermira link up for Cimzia in dermatology

03-07-2014

Belgium’s largest drugmaker UCB and Dermira, a privately held USA-based dermatology company, have entered…

CanadaCimziaDermatologicalsDermiraEuropeLicensingPharmaceuticalResearchUCBUSA

Chronic under-reporting of pharma R&D investment works against Canada

Chronic under-reporting of pharma R&D investment works against Canada

30-06-2014

A new KPMG study shows that R&D investments made by Canada's innovative pharmaceutical sector continue…

ApostropheCADCanadaEnglish spellingFinancialPharmaceuticalPharmaceutical sectorPoliticsPunctuationResearch

US FDA grants Valeant approval for Jublia NDA

US FDA grants Valeant approval for Jublia NDA

09-06-2014

Canadian drugmaker Valeant Pharmaceuticals International’s US subsidiary has received approval from…

CanadaDermatologicalsefinaconazoleJubliaPharmaceuticalRegulationUS Food and Drug AdministrationValeant Pharmaceuticals

Quebec first province to add Victoza to the drug benefit formulary

Quebec first province to add Victoza to the drug benefit formulary

04-06-2014

The Canadian subsidiary of Danish diabetes care giant Novo Nordisk says that the Quebec government has…

CanadaDiabetesFinancialHealthcareNovo NordiskPharmaceuticalVictoza

AbbVie files for Canadian approval of all-oral, interferon-free hepatitis C therapy

22-05-2014

US drugmaker AbbVie has filed a New Drug Submission to Health Canada seeking approval for its investigational,…

AbbVieAnti-viralsCanadaPharmaceuticalRegulation

USTR expresses growing concerns on IP protection in India and other markets

01-05-2014

The Office of the US Trade Representative (USTR) has released its annual “Special 301” Report on…

CanadaIndiaPatentsPharmaceuticalUSA

1 to 25 of 36 results

Back to top